Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
405 hedge funds and large institutions have $11.5B invested in Abiomed Inc in 2018 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 112 increasing their positions, 162 reducing their positions, and 36 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 6 → 15 (+9)
133% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 36
57% more capital invested
Capital invested by funds: $7.31B → $11.5B (+$4.15B)
12% more funds holding
Funds holding: 361 → 405 (+44)
6% less call options, than puts
Call options by funds: $87.8M | Put options by funds: $93.8M
31% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 162
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$199M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$75.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$62.7M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$45.7M |
| 5 |
BlackRock
New York
|
+$43.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$113M |
| 2 |
Primecap Management
Pasadena,
California
|
-$65.1M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$64.3M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$60.5M |
| 5 |
Millennium Management
New York
|
-$50.1M |
ABMD Hedge Fund Activity: Q1 2018 in Review
405 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2018, worth a combined $11.5B — up 57% from $7.31B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new ABMD positions and 36 closed out — a net gain of 48 holders — while 112 added to existing stakes and 162 trimmed.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $199M. The largest seller was Essex Woodlands Management, cutting an estimated $113M.
- 405 institutional investors held Abiomed Inc (ABMD) as of Q1 2018, up from 361 in Q4 2017.
- Funds reported $11.5B of Abiomed Inc stock for Q1 2018, up 57% quarter-over-quarter.
- 84 funds opened new Abiomed Inc positions in Q1 2018 and 36 closed out, a net change of +48 holders.
- The largest Abiomed Inc buyer in Q1 2018 was Winslow Capital Management, an estimated $199M added.
- The largest Abiomed Inc seller in Q1 2018 was Essex Woodlands Management, an estimated $113M sold.
Based on aggregated 13F filings for Q1 2018.